Goodwin is home to a highly experienced healthcare and life sciences team, capable of advising clients on strategic acquisitions, joint ventures, fundraising and cross-border transactions. Spearheading the team, Anne-Charlotte Rivière specialises in venture capital, M&A and private equity transactions. Marie Fillon is a name to note for strategic partnerships, including licences, collaborations, and distribution agreements. Maxence Bloch brings in-depth knowledge of M&A transactions, in particular leveraged buyouts and private equity transactions.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘An efficient team, capable of leading large-scale M&A projects by mobilizing the right experts.’
- ‘Marie Fillon has deep knowledge of the life sciences start-up sector in France.’
- ‘Marie Fillon has the ability to be business-oriented - a rare quality because IP is very often focused on patent creation and less on their day-to-day management in contracts.'
- ‘Anne-Charlotte Rivière is recommended for her availability, listening skills, empathy, good interpersonal skills, and expertise.’
- 'Thomas Dupont Sentilles has extensive experience in growth phases for high-growth companies.’
- ‘Expertise in understanding the underlying issues. Close client relationships. High-quality team.’
Key clients
- AlgoTx
- AQEMIA
- Biomunex
- Cerba Healthcare
- GENFIT
- Germitec
- Moon Surgical
- Stilla Technologies
- TRICares
- UroMems
- AdBio Partners
- Andera Partners
Work highlights
Advising Stilla Technologies on its acquisition by Bio-Rad.
Advising Genfit on a non-dilutive capped royalty financing agreement with HealthCare Royalty (HCRx) for up to €185 million in exchange for a portion of the royalties on sales of Iqirvo® (elafibranor).
Adivising TRICares on its $50 million Series D financing round.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Anne-Charlotte Rivière
Other key lawyers
Marie Fillon; Maxence Bloch; Thomas Dupont Sentilles; Guilhem Richard